跳至主要内容
临床试验/NCT05635123
NCT05635123招募中不适用

A Cohort Study of Uterine Malignancies

Women's Hospital School Of Medicine Zhejiang University1 个研究点 分布在 1 个国家目标入组 6,200 人开始时间: 2023年9月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
6,200
试验地点
1
主要终点
progression free survival (PFS)

研究概览

简要总结

The purposes of current study were to explore the relationship between cervical cancer/endometrial cancer and demographic information, behavior and life style, pregnancy-related factors, and disease history, and to study the factors affecting the prognosis of cancers. In addition, omics tests were performed on the biological specimens to identify the diagnostic markers and prognostic biomarkers.

详细描述

After being informed about the study and potential risks, all patients who meet the eligibility requirements will be enrolled.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age 20-75 years;
  • Women with cervical cancer or endometrial cancer with a definite pathological diagnosis for the first time;
  • Women attending a health check-up;
  • Obtain informed consent and sign an informed consent form.

排除标准

  • Patients who are unable to cooperate with the investigations such as mental disorders or cognitive impairment;
  • Patients with cancer other than cervical cancer or endometrial cancer;
  • Women who have received hysterectomy or pelvic radiation therapy previously.

结局指标

主要结局

progression free survival (PFS)

时间窗: 60 months

progression free survival for patients with cervical cancer or endometrial cancer

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验